Russia vaccine could get EUA in 2 weeks

The Emergency Use Authorization (EUA) for Russia’s Gamaleya vaccine would likely be approved in one or two weeks, vaccine czar Carlito Galvez Jr. said on Sunday.

The Food and Drug Administration (FDA) is in the “advanced stage” of clearing the Sputnik V vaccine, Galvez said during the ceremony for the rollout of the AstraZeneca vaccine held at QualiMed Hospital in Sta. Rosa Laguna.